Cost-Effectiveness of a Specialist Smoking Cessation Package Compared with Standard Smoking Cessation Service for People with Severe Mental Illness in England: A Trial-Based Economic Evaluation From the SCIMITAR+ Study

2019 ◽  
Author(s):  
Jinshuo Li ◽  
Caroline Fairhurst ◽  
Emily Peckham ◽  
Della Bailey ◽  
Catherine Arundel ◽  
...  
Keyword(s):  
Mental Illness ◽  
Smoking Cessation ◽  
Economic Evaluation ◽  
Cost Effectiveness ◽  
Severe Mental Illness ◽  
Smoking Cessation Service

Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness

1999 ◽  
Vol 174 (4) ◽  
pp. 346-352 ◽  
Author(s):  
Anthony F. Lehman ◽  
Lisa Dixon ◽  
Jeffrey S. Hoch ◽  
Bruce Deforge ◽  
Eimer Kernan ◽  
...  
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
Cost Effectiveness ◽  
Severe Mental Illness ◽  
Usual Care ◽  
Assertive Community Treatment ◽  
Cost Effective ◽  
Homeless Persons ◽  
Community Treatment ◽  
Stable Housing

BackgroundHomelessness is a major public health problem among persons with severe mental illness (SMI). Cost-effective programmes that address this problem are needed.AimsTo evaluate the cost-effectiveness of an assertive community treatment (ACT) programme for these persons in Baltimore, Maryland.MethodsA total of 152 homeless persons with SMI were randomly allocated to either ACT or usual services. Direct treatment costs and effectiveness, represented by days of stable housing, were assessed.ResultsCompared with usual care, ACT costs were significantly lower for mental health in-patient days and mental health emergency room care, and significantly higher for mental health out-patient visits and treatment for substance misuse. ACT patients spent 31% more days in stable housing than those receiving usual care. ACT and usual services incurred $242 and $415 respectively in direct treatment costs per day of stable housing, an efficiency ratio of 0. 58 in favour of ACT. Patterns of care and costs varied according to race.ConclusionACT provides a cost-effective approach to reducing homelessness among persons with severe and persistent mental illnesses.

scholarly journals Smoking cessation in severe mental illness: combined long-term quit rates from the UK SCIMITAR trials programme

2019 ◽  
pp. 1-3 ◽  
Author(s):  
Simon Gilbody ◽  
Emily Peckham ◽  
Della Bailey ◽  
Catherine Arundel ◽  
Paul Heron ◽  
...  
Keyword(s):  
Mental Illness ◽  
Smoking Cessation ◽  
Severe Mental Illness ◽  
Short Term ◽  
Cessation Intervention ◽  
Term Trial ◽  
Short And Long Term ◽  
The Uk ◽  
Full Trial

Summary Smoking contributes to health inequalities for people with severe mental illness (SMI). Although smoking cessation interventions are effective in the short term, there are few long-term trial-based estimates of abstinence. The SCIMITAR trials programme includes the largest trial to date of a smoking cessation intervention for people with SMI, but this was underpowered to detect anticipated long-term quit rates. By pooling pilot and full-trial data we found that quit rates were maintained at 12 months (OR = 1.67, 95% CI 1.02–2.73, P = 0.04). Policymakers can now be confident that bespoke smoking cessation interventions produce successful short- and long-term quitting.

Sign in / Sign up

Export Citation Format

Share Document